Objective: Fenestrated and branched endovascular aneurysm repair (FB-EVAR) is a valid option to treat juxtarenal and pararenal abdominal aortic aneurysms and thoracoabdominal aortic aneurysms. Because successful deployment depends on complex maneuvers, hostile iliac artery anatomy (HIA) can prejudice the FB-EVAR outcome. The aim of the study was to evaluate the impact of HIA on FB-EVAR outcome.
Fenestrated and branched endovascular aneurysm repair (FB-EVAR) is an effective option in the treatment of aortic aneurysms involving renal and splanchnic arteries in patients at high surgical risk who are unfit for open repair, as reported by several experiences in patients with juxtarenal and pararenal abdominal aortic aneurysms (AAAs) [1] [2] [3] [4] and thoracoabdominal aortic aneurysms (TAAAs). [5] [6] [7] However, similar to standard EVAR, 8 the effectiveness or feasibility of FB-EVAR is dependent on specific Bologna, Italy (e-mail: enrico.gallitto@gmail.com).
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anatomic aortoiliac criteria. Focusing on the iliac artery anatomy, a 20F to 24F access is always necessary to introduce the fenestrated or branched module, and a large contralateral sheath (18F-24F according to the number of fenestrations) is also required to cannulate the target visceral vessels (TVVs) in fenestrated devices. The presence of narrow iliac arteries, severe or extensive calcifications, angulations, or previous surgical or endovascular graft greatly limits the endograft's maneuverability. However, successful endovascular repair depends on complex and fine maneuversdendograft rotation, accurate deployment, and visceral vessel cannulation and stenting.
Because there are no papers focusing on the effect of hostile iliac artery anatomy (HIA) on FB-EVAR outcome, our study aimed to evaluate the impact of these anatomic features in this setting.
METHODS
Selection of patients. The preoperative, procedural, and follow-up data of patients who underwent FB-EVAR with Cook Zenith platform (Cook Medical, Bloomington, Ind) between 2010 and December 2015 were prospectively collected in a dedicated electronic database and analyzed. Patients were retrospectively categorized according to iliac artery anatomy into friendly iliac artery anatomy (FIA) and HIA. All patients enrolled in this study signed a dedicated informed consent. The study was approved by the local Institutional Review Board.
Preoperative planning and iliac artery evaluations. Patients were studied through thoracoabdominal computed tomography angiography (CTA) performed within 3 months preoperatively. Postprocessing evaluations (multiplanar, three-dimensional, center lumen line reconstructions) were elaborated by a dedicated software for vessel analysis (3mensio Vascular, Bilthoven, The Netherlands). The FB-EVAR implant was planned by the same surgical team that performed the procedure, and the plan was confirmed by the Cook Zenith planning center for fenestrated and branched endografts. Patients with severe neck angulations (>45 degrees) were not considered fit for FB-EVAR.
For this study, the iliac artery evaluation was performed by two vascular surgeons (R.P., E.G.) with experience in EVAR procedure planning and follow-up. They were blinded to the patient's history and outcomes, and they also postprocessed all the CTA images on the same software used for the preoperative planning.
Definitions. HIA was defined as the presence of at least one of the following features: severe (>90-degree) iliac angle, extensive (>50%) iliac circumferential calcification, hemodynamic iliac stenosis or obstruction, external iliac artery diameter <7 mm, or previous aortoiliac/femoral surgical or endovascular graft. Iliac artery angles were measured on the volume rendering reconstruction, achieved by a dedicated software (3mensio) using a dedicated electronic caliper.
All the iliac stenoses were evaluated on preoperative CTA. When they reduced the iliac artery lumen about >50%, duplex ultrasound was performed to evaluate the hemodynamic significance. When the peak systolic velocity ratio (peak systolic velocity below/above stenosis) was >2.5 or the blood flow below the stenosis was not physiologic (not three-phasic flow wave), the iliac artery stenosis was defined as hemodynamic.
Technical success (TS) was defined as the correct deployment of the endograft at the intended location, without type I or type III endoleak, TVV loss, endograft limb stenosis-occlusion or kinking, conversion to open repair, and 24-hour mortality.
Intraoperative adjunctive maneuvers (IAMs) were defined as at least one of the following: iliac percutaneous transluminal angioplasty (PTA)/stenting, surgical iliac conduit, need for several intra-aortic graft rotations, or several attempts of TVV cannulation. Planned and unplanned IAMs were considered for the study evaluations. Several intra-aortic graft rotations were defined as multiple attempts (more than three times) of device rotations or maneuvers before obtaining the correct fenestrated or branched endograft position (according to the TVV ostia).
Intraoperative technical problems were defined as at least one of the following: iliac rupture, significant endograft twisting, difficult TVV cannulations, TVV injuries, or TVV loss.
Significant endograft twisting was considered a "candy cane" complicationdendograft rotation >30 degrees in case of a fenestrated endograft or >90 degrees in case ARTICLE HIGHLIGHTS of a branched endograft (these findings were detected intraoperatively under fluoroscopy guidance and according to fenestrated and branched radiopaque markers). We defined this cutoff according to the differences reported for fenestrated and branched procedures. The branch technology guarantees more flexibility and freedom for the TVV cannulation, and it permits this maneuver also in cases of not perfect deployment (the only real limit is the level of branch deployment, which must be at least 1-1.5 cm above the TVV ostia). In cases of fenestration, even a few millimeters of uncorrected deployment could lead to difficult or impossible TVV cannulation.
Difficult TVV cannulation was defined as several unsuccessful attempts (more than three times) before obtaining effective TVV catheterization, different angiographic catheter or introducer used (more than two), need to perform predilation of the TVV ostia, or need to use 0.014-or 0.018-inch guidewires to achieve TVV cannulation. TVV injuries were defined as rupture, dissection, or loss of the TVV.
End points. Early end points were TS, IAMs, intraoperative technical problems, and 30-day mortality. Follow-up end points were survival, TVV patency, and freedom from reintervention (FFR).
Follow-up. As previously reported, 7, 9 all patients entered into a dedicated FB-EVAR follow-up protocol after the procedure. Laboratory evaluation of renal, hepatic, and pancreatic function and thoracoabdominal CTA and contrast-enhanced ultrasound (CEUS) were performed before discharge. The home surveillance program was performed by using plain radiography, Doppler ultrasound or CEUS, and CTA. Table I 
RESULTS

Selection of patients.
Between 2010 and 2015, overall 143 cases of juxtarenal and pararenal AAAs and TAAAs were treated. There were 94 patients (66%), at high surgical risk, who underwent FB-EVAR and were enrolled in the study. The mean age was 73 6 6 years (range, 65-82 years), and 87% of patients were male; 78% were American Society of Anesthesiologists (ASA) class 3 and 22% ASA class 4. Demographics, cardiovascular risk factors, and comorbidities are reported in Table II . The mean aneurysm diameter was 60 6 10 mm (range, 51-75 mm). Fifty-nine (63%) cases were juxtarenal and pararenal AAAs, and 35 (37%) were TAAAs. Tube and bifurcated endografts were used in 29 (31%) and 65 (69%) cases, respectively. Double reducing tie was used in 13 (14%) patients. There were 72 cases (76%) treated by endograft with only fenestrations, 13 cases (14%) with only branches, and 9 cases (10%) with both fenestrations and branches. The total number of TVVs was 324, with a mean of 3.4 6 1 vessels/patient.
Iliac artery anatomy. Preoperative HIA features are summarized in Table III ; 60 (64%) patients had HIA and 34 had (36%) FIA. Patients with HIA and FIA had similar preoperative clinical characteristics, except for coronary artery disease (HIA 47% vs FIA 24%; P ¼ .03), peripheral artery occlusive disease (HIA 12% vs FIA 0%; P ¼ .04), and ASA class 4 (HIA 28% vs FIA 9%; P ¼ .03; Table II ). According to the number of hostile iliac artery features for each patient, three grades of HIA were clustered: grade 0 (34 patients, FIA), grade 1 (39 patients, one or two hostile features), and grade 2 (21 patients, three or more hostile features).
Procedure. In 90 cases (96%), the FB-EVAR procedure was performed under general anesthesia. Intraoperative adjunctive iliac procedures were performed in 32 cases 
CEUS, Contrast-enhanced ultrasound; CTA, computed tomography angiography.
to ensure the endograft or contralateral sheath access: surgical conduit, 14 (15%; endograft with only fenestrations, 9; only branches, 3; both branches and fenestrations, 2); and PTA/stenting, 27 (29%). Nine (9.6%) patients required a surgical iliac conduit for the main body insertion and PTA or PTA/stenting of the contralateral iliac access. Iliac rupture requiring repair (sealed by a selfexpandable covered stent) occurred in one female patient with HIA, in whom a surgical conduit was not performed. Endograft twisting and difficult TVV cannulation occurred in 13 Five renal arteries were not cannulated and abandoned (three branches, two fenestrations). TVV injuries occurred in five cases; there were two renal artery dissections (two fenestrations: one solved with adjunctive stenting and one not solved in association with intraoperative renal artery loss) and three renal artery ruptures (two fenestrations and one branch: main trunkdsolved by adjunctive stent graft; collateral branchdsolved by collateral embolization by vascular plug; distal parenchymal vesselsd solved by microcoil embolization).
The TVV patency rate was 97.8% (HIA 94.7% vs FIA 98.3%; P ¼ .3). The TS was 96% (HIA 97% vs FIA 95%; P ¼ .6).
There were no differences (P ¼ .40) in terms of TS among endografts with only fenestrations (96%), with only branches (100%), and with both fenestrations and branches (89% Table IV ).
There were statistically significant differences between grades 0, 1, and 2 of HIA in terms of endograft malorientation (grade 0, 3%; grade 1, 15%; grade 2, 29%; P ¼ .026), difficult TVV cannulation (grade 0, 18%; grade 1, 41%; grade 2, 52%; P ¼ .019), surgical iliac conduit (grade 0, 0%; grade 1, 8%; grade 2, 52%; P ¼ .0001), iliac PTA/stenting (grade 0, 18%; grade 1, 28%; grade 2, 48%; P ¼ .040), and IAMs (grade 0, 32%; grade 1, 44%; grade 2, 76%; P ¼ .006).
Early endoleaks. At completion angiography, no type I or type III endoleaks were detected, and there were 11 (12%) type II endoleaks. At postoperative CTA, three type III endoleaks (one successfully treated, two spontaneously sealed at 3 months) and one type IB endoleak (successfully treated) were reported. Thirty-day mortality. Overall, four patients died in the perioperative period (30-day mortality rate was 4%: HIA, 3%; FIA, 5%; P ¼ .9). A patient treated electively for type IV TAAA died on postoperative day 4 of intestinal ischemia due to an acute occlusion of the superior mesenteric artery stent graft. A patient successfully treated for a contained rupture of a type II TAAA died on postoperative day 7 of respiratory failure. A patient treated electively for an unruptured juxtarenal AAA died of a cardiac arrest on postoperative day 16. A patient treated electively for a type III TAAA died on postoperative day 22 of multiorgan failure after the intraoperative iliac artery rupture described before. There were no differences in postoperative renal function worsening (>30% of the baseline glomerular filtration rate) between the HIA (13%) and FIA (12%) groups.
Follow-up. At a mean follow-up of 24 6 17 months, no aneurysm-related mortality occurred. The overall survival was 87% and 71% at 1 year and 3 years, respectively; the estimated survival function is reported in Fig 4 according to Kaplan-Meier analysis. HIA had a significantly lower 3-year survival compared with FIA (60% vs 92%; respectively; P ¼ .02). On multivariate analysis, HIA was an independent predictor of late mortality (OR, 3.6; 95% CI, 1.1-13.2; P ¼ .04).
The FFR at 1 year, 2 years, and 3 years was 89%, 87%, and 87%, respectively (Fig 5) . The TVV patency at 1 year, 2 years, and 3 years was 95%, 92%, and 92%, respectively (Fig 6) . At 3 years, FFR (87%) and TVV patency (92%) were similar in the two groups. In Table V 
DISCUSSION
This study shows how iliac artery anatomy can influence the FB-EVAR outcome in endovascular repair of juxtarenal and pararenal AAAs and TAAAs. Although we have been unable to find in the literature other dedicated studies dealing specifically with this subject, we believe that the problem of HIA in this procedure is of paramount importance. FB-EVAR procedures are technically demanding, requiring extreme accuracy in endograft deployment. [1] [2] [3] [4] [5] [6] [7] All the necessary maneuvers are
complex, yet precise movements are needed for TVV cannulation. [1] [2] [3] [4] [5] [6] [7] Furthermore, large sheaths must be introduced in both iliac vessels (two for fenestrated endograft, one for branched endograft) to accomplish the whole procedure. [1] [2] [3] [4] [5] [6] [7] For the purpose of our analysis, HIA was defined as the presence of at least one of the following features: severe (>90-degree) iliac angle, extensive (>50%) iliac circumferential calcification, hemodynamic iliac stenosis or obstruction, external iliac artery diameter <7 mm, and previous aortoiliac/femoral surgical or endovascular graft. With the exception of the last one, all these features were reported by Chaickof et al 8 
in the Society for Vascular
Surgery reporting standard. The presence of a previous aortoiliac/femoral surgical or endovascular graft has been added in our work because the femoral/iliac access can be difficult in these instances. As a matter of fact, the frictional forces created by the stiffness and the small luminal diameter of the previous surgical or endovascular graft hamper the movement of the fenestrated device.
9-11
On the basis of our definition, the presence of HIA was detected in as many as 60 cases (64%) of 94 consecutive patients treated with FB-EVAR (39 patients with one or two and 21 patients with three or more hostile iliac artery features). Despite that, the overall TS rate was 96%, which compares favorably with other large experiences reported from dedicated centers.
1,3,4,6,12,13 Because the TS was similar in HIA and FIA (97% and 95%, respectively), FB-EVAR repair can be performed effectively and safely in a high percentage of cases even in the presence of problem iliac access; however, it has to be taken into account that particular attention and adjunctive care are necessary in the presence of HIA, especially when more than two hostile iliac artery features are present. First of all, HIA is associated with longer procedure and fluoroscopy times because significantly more IAMs are necessary to overcome technical hurdles, either A, Overall survival. B, Survival in hostile iliac artery anatomy (HA) vs friendly iliac artery anatomy (FA). In FA, survival was 92% 6 5% at 12, 24, and 36 months, respectively. In HA, survival was 83% 6 5%, 60% 6 9%, and 60% 6 9% at 12, 24, and 36 months, respectively (log-rank P ¼ .01).
expected or unexpected. HIA can have an impact on FB-EVAR procedures through a dual mechanism. At the beginning, it can impede the introduction and the progression of the FB-EVAR endograft. In these cases, adjunctive maneuvers (planned or unplanned), such as the use of dilators, pre-emptive PTA and PTA/stenting, or iliac surgical conduit, can be used to solve it. Next, the presence of a narrow, calcific, angulated iliac artery or a previous graft limits the endograft's maneuverability, which requires fine rotational or craniocaudal movements at the visceral vessel levels. These aspects are reported in both fenestrated and branched endografts. In these cases, the deployment of the endograft could be imprecise, leading to a difficult or even impossible TVV cannulation, with subsequent higher risk of a TVV lesion. On multivariate analysis, severe common and external iliac artery calcifications and external iliac diameter <7 mm were risk factors for IAMs. . In FA, FFR was 82% 6 8% at 12, 24, and 36 months, respectively. In HA, FFR was 93% 6 3%, 90% 6 5%, and 90% 6 5% at 12, 24, and 36 months, respectively (log-rank P ¼ .53). . In FA, TVV patency was 89% 6 7% at 12, 24, and 36 months, respectively. In HA, FFR was 98% 6 2%, 93% 6 4%, and 93% 6 4% at 12, 24, and 36 months, respectively (log rank P ¼ .53).
We think that to avoid these problems and severe complications, such as an iliac rupture, performance of a surgical iliac conduit is always recommended in case of narrow and calcific access. It is important to underline that patients with three or more HIA features have worse results than patients with one or two HIA features or with FIA, in terms of endograft malorientation, difficult TVV cannulation, surgical iliac conduit, iliac PTA/stenting, and IAMs. We also evaluated if there were any differences between fenestrated and branched endografts. There were no differences in terms of TS, but there were differences in terms of TVV complications and endograft twisting or malrotations and iliac PTA/stenting. Branched endografts had a higher incidence of TVV complications and malrotations. This sounds reasonable if one considers that branched endografts are usually deployed for extensive TAAA (types I, II, III), and they are longer endografts in comparison with fenestrated devices (higher risk of twisting). Moreover, patients treated by only the branched endograft require only one adequate iliac access for the procedure (vs access of both iliac vessels for the fenestrated endograft). It could explain the lower number of iliac PTA/stenting of the branched endograft group.
In our study, we are reporting only the early and midterm results (27 6 14 months) of FB-EVAR; however, this technology is relatively new, and there are not many reports with long-term results available. 3, 4, 6, 12, 13 Our TVV patency and FFR data are comparable with other experiences in the literature 3,4,14-16 and were not influenced by the presence of HIA in our series. ASA class, coronary artery disease, and peripheral arterial disease are usually considered strong predictors of late mortality. In this study, patients with HIA had a higher rate of these comorbidities in comparison with patients with FIA, and this can be a possible confounding factor in the analysis of follow-up survival within the two groups. Anyway, the multivariate analysis showed that HIA is an independent risk factor for late mortality.
This study has several limits. The number of patients is relatively small and the follow-up is limited. Moreover, the stratification of the iliac artery anatomy characteristics was made retrospectively. Finally, the procedures were performed by the same vascular team during a study period of 5 years, and the learning curve effect of the operators was not considered. This latter point is particularly important because expertise is a key factor in treating challenging FB-EVAR cases, but the number of cases is too small to divide the cohort of patients into different subgroups (early vs mid and late period).
According to these results, the anatomy of the iliac artery can be considered one of the crucial points of FB-EVAR procedures. Accurate FB-EVAR preoperative planning is important to predict, to prevent, or to avoid the problems associated with HIA during the procedure, and in case of HIA, the use of pre-emptive PTA of the iliac artery or surgical iliac conduit is strongly suggested to facilitate FB-EVAR deployment and visceral vessel cannulation. The lower late survival rate of patients with HIA should also be considered in the indications to the treatment of juxtarenal and pararenal AAAs and TAAAs.
CONCLUSIONS
HIA does not significantly affect the early outcome of FB-EVAR in terms of TS and 30-day mortality. However, procedures performed in patients with these characteristics are technically more demanding (need of IAMs), and late mortality is increased. Iliac characteristics should be carefully evaluated for accurate indication of FB-EVAR and planning. Both patients underwent fenestrated and branched endovascular aneurysm repair (FB-EVAR) for thoracoabdominal aortic aneurysm (TAAA), and they had a single kidney. Even if the renal branch was recanalized, the patients needed hemodialysis at 1 month and 3 months, respectively.
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